MYL3/CMLC1 Antikörper
-
- Target Alle MYL3/CMLC1 (MYL3) Antikörper anzeigen
- MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser MYL3/CMLC1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of MYL3 expressed in E. coli.
- Klon
- 3F8
- Isotyp
- IgG1
- Top Product
- Discover our top product MYL3 Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 20, Issue 7, pp. 865-73, (2006) (PubMed).
: "The functional domains of human ventricular myosin light chain 1." in: Biophysical chemistry, Vol. 106, Issue 1, pp. 57-66, (2003) (PubMed).
: "
-
Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 20, Issue 7, pp. 865-73, (2006) (PubMed).
-
- Target
- MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))
- Andere Bezeichnung
- MYL3 (MYL3 Produkte)
- Synonyme
- CMD1S antikoerper, CMH1 antikoerper, MPD1 antikoerper, MYHCB antikoerper, SPMD antikoerper, SPMM antikoerper, B-MHC antikoerper, MyHC-I antikoerper, Myhc-b antikoerper, Myhcb antikoerper, beta-MHC antikoerper, MLC1s antikoerper, MLC1v antikoerper, Mylc antikoerper, VLC1 antikoerper, Mylc1v antikoerper, CMH8 antikoerper, MLC1SB antikoerper, MLC1V antikoerper, mlc1v antikoerper, myl3-a antikoerper, myl3-b antikoerper, myl3.L antikoerper, zgc:103441 antikoerper, myosin heavy chain 7 antikoerper, myosin, heavy polypeptide 7, cardiac muscle, beta antikoerper, myosin, light polypeptide 3 antikoerper, myosin light chain 3 antikoerper, myosin light chain 3 S homeolog antikoerper, cardiac myosin light chain-1 antikoerper, MYH7 antikoerper, Myh7 antikoerper, Myl3 antikoerper, MYL3 antikoerper, myl3.S antikoerper, cmlc1 antikoerper
- Hintergrund
-
Description: Myosins are a large superfamily of motor proteins that move along actin filaments, while hydrolyzing ATP. Myosin is the major component of thick muscle filaments, and is a long asymmetric molecule containing a globular head and a long tail. The molecule consists of two heavy chains and four light chains. Activation of smooth and cardiac muscle primarily involves pathways which increase calcium and myosin phosphorylation resulting in contraction. Myosin light chain phosphatase acts to regulate muscle contraction by dephosphorylating activated myosin light chain. MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Human myosin light chain has clinical application as a cardiac marker. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
Aliases: CMH8, VLC1, MLC1V, MLC1SB
- Molekulargewicht
- 22 kDa
- Gen-ID
- 4634
- HGNC
- 4634
-